Actively Recruiting
Japanese CTO PCI Expert Registry
Led by Kurashiki Central Hospital · Updated on 2013-07-02
19000
Participants Needed
1
Research Sites
752 weeks
Total Duration
On this page
Sponsors
K
Kurashiki Central Hospital
Lead Sponsor
J
Japanese CTO PCI Expert Registry investigators
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.
CONDITIONS
Official Title
Japanese CTO PCI Expert Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients eligible for PCI
- Patients who underwent PCI for CTO lesions with TIMI 0 (complete blockage)
- Lesions must have an occlusive period longer than 3 months or unknown duration
- Lesions located in main coronary arteries (segments 1-3, 5-8, 11, 13), branches with large perfusion areas (segments 4PL, 9/10, 12), or grafts
You will not qualify if you...
- Patients judged ineligible for PCI in clinical practice
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kurashiki Central Hospital
Kurashiki, Japan, 710-8602
Actively Recruiting
Research Team
K
Keiko Oka
CONTACT
H
Harumi Katoh, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here